Cargando…
CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway
Hepatocellular carcinoma (HCC) is a malignancy of considerable concern due to its continuous increase in morbidity and mortality. This study attempts to identify the molecules that play a key role in the progression of HCC, explore its potential mechanism, and provide more target choices for targete...
Autores principales: | Liu, Xitao, Zhao, Defang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366641/ https://www.ncbi.nlm.nih.gov/pubmed/34408811 http://dx.doi.org/10.1080/19768354.2021.1953142 |
Ejemplares similares
-
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
por: Shi, Lei, et al.
Publicado: (2010) -
JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020) -
CEP55 Promotes Cell Motility via JAK2–STAT3–MMPs Cascade in Hepatocellular Carcinoma
por: Li, Minjing, et al.
Publicado: (2018) -
Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway
por: Wang, Ruoyu, et al.
Publicado: (2021) -
CKS1B promotes cell proliferation and invasion by activating STAT3/PD‐L1 and phosphorylation of Akt signaling in papillary thyroid carcinoma
por: Wang, Hui, et al.
Publicado: (2020)